Health Economics Sr Associate - Manager

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life‑changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Location:

 Basingstoke, UK (hybrid)

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life‑changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

The Health Outcomes and Health Technology Assessment team (HOHTA) is the UK team accountable for gaining national access for our medicines at launch via Health Technology Assessment submissions to NICE, SMC, AWMSG etc. We are a part of the Pricing, Reimbursement & Access (PRA) function which covers the Northern European Hub (UK and Ireland plus Nordic countries) and includes a field‑based team.

• Accountable for developing the health economic strategy and delivering Health Technology Assessment (HTA) submissions to gain national access for Lilly medicines in the UK and Ireland (and providing support across the Northern European Hub).
• Develop UK health economic and HTA strategies for Lilly medicines and line extensions.
• Lead all aspects of the dossier development and submission process for NICE, Scottish Medicines Consortium, All Wales Medicines Strategy Group, National Centre of Pharmacoeconomics and other health technology assessment groups.
• Select, manage, and support relevant market access agencies (UK) to prepare and write HTA submissions and ensure the delivery of quality outputs.
• Provide support and guidance to colleagues across the NE Hub in their HTA submissions
• Partner with the International Value & Access (IVA) function in the development and review of health economic models and associated deliverables (model reports, SLRs, NMAs etc) to ensure they are suitable for the UK HTA environment.
• Represent the Lilly health economic case responding to queries at NICE and SMC appraisal meetings.
• Review and monitor competitor/comparator HTA submissions for key insights, also collaborating with Marketing/Brand teams, Medical and Real‑World Evidence.
• Support our UK PRA team and lead on the development of local health economic tools and materials to improve adoption of Lilly medicines for local pa…